Authors:
Ferron, GM
Preston, RA
Noveck, RJ
Pockros, P
Mayer, P
Getsy, J
Turner, M
Abell, M
Paul, J
Citation: Gm. Ferron et al., Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction, CLIN THER, 23(8), 2001, pp. 1180-1192
Citation: Gm. Ferron et al., Pharmacodynamic modeling of pantoprazole's irreversible effect on gastric acid secretion in humans and rats, J CLIN PHAR, 41(2), 2001, pp. 149-156
Citation: Gm. Ferron et al., Lack of pharmacokinetic interaction between oral pantoprazole and cisapride in healthy adults, J CLIN PHAR, 39(9), 1999, pp. 945-950
Authors:
Zimmerman, JJ
Ferron, GM
Lim, HK
Parker, V
Citation: Jj. Zimmerman et al., The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin), J CLIN PHAR, 39(11), 1999, pp. 1155-1161
Citation: Gm. Ferron et al., Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats, J PHAR BIOP, 27(1), 1999, pp. 1-21
Authors:
Ball, SE
Scatina, JA
Kao, J
Ferron, GM
Fruncillo, R
Mayer, P
Weinryb, I
Guida, M
Hopkins, PJ
Warner, N
Hall, J
Citation: Se. Ball et al., Population distribution and effects on drug metabolism of a genetic variant in the 5 ' promotor region of CYP3A4, CLIN PHARM, 66(3), 1999, pp. 288-294
Citation: Gm. Ferron et Wj. Jusko, Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits, PHARM RES, 15(12), 1998, pp. 1888-1894